Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2016
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort
Laura Q M Chow, Robert Haddad, Shilpa Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2026
A Phase 2 Trial of an Extended-release siRNA Implant Targeting KRAS G12D/V in Locally Advanced Pancreatic Cancer
Brinda Alagesan, Anna M Varghese, Celina Ang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 2019
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Aurelien Marabelle, Dung T Le, Paolo A Ascierto, et al.
Gut
|
July 12, 2014
FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study
Ravit Geva, Loredana Vecchione, Konstantinos T Kalogeras, et al.
Nature Medicine
|
May 27, 2020
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Bruno Bockorny, Valerya Semenisty, Teresa Macarulla, et al.
JAMA Oncology
|
March 16, 2018
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial
Charles S Fuchs, Toshihiko Doi, Raymond W Jang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2026
Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848
Ross A Abrams, Kathryn A Winter, Karyn A Goodman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2023
Data From a One-Stop-Shop Comprehensive Cancer Screening Center
Ezra Bernstein, Shahar Lev-Ari, Shiran Shapira, et al.
Cancer Discovery
|
February 17, 2022
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors
Alexander Muik, Elena Garralda, Isil Altintas, et al.
Journal for Immunotherapy of Cancer
|
February 15, 2019
Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
Sneha Berry, Nicolas Giraldo, Peter Nguyen, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2016
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort
Laura Q M Chow, Robert Haddad, Shilpa Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2026
A Phase 2 Trial of an Extended-release siRNA Implant Targeting KRAS G12D/V in Locally Advanced Pancreatic Cancer
Brinda Alagesan, Anna M Varghese, Celina Ang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 2019
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Aurelien Marabelle, Dung T Le, Paolo A Ascierto, et al.
Gut
|
July 12, 2014
FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study
Ravit Geva, Loredana Vecchione, Konstantinos T Kalogeras, et al.
Nature Medicine
|
May 27, 2020
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Bruno Bockorny, Valerya Semenisty, Teresa Macarulla, et al.
JAMA Oncology
|
March 16, 2018
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial
Charles S Fuchs, Toshihiko Doi, Raymond W Jang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2026
Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848
Ross A Abrams, Kathryn A Winter, Karyn A Goodman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2023
Data From a One-Stop-Shop Comprehensive Cancer Screening Center
Ezra Bernstein, Shahar Lev-Ari, Shiran Shapira, et al.
Cancer Discovery
|
February 17, 2022
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors
Alexander Muik, Elena Garralda, Isil Altintas, et al.
Journal for Immunotherapy of Cancer
|
February 15, 2019
Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
Sneha Berry, Nicolas Giraldo, Peter Nguyen, et al.
Page
of 9